PMID- 32076039 OWN - NLM STAT- MEDLINE DCOM- 20201112 LR - 20210218 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 10 IP - 1 DP - 2020 Feb 19 TI - Semi-quantitative versus quantitative assessments of late gadolinium enhancement extent for predicting spontaneous ventricular tachyarrhythmia events in patients with hypertrophic cardiomyopathy. PG - 2920 LID - 10.1038/s41598-020-59804-8 [doi] LID - 2920 AB - Extent of late gadolinium enhancement (LGE) quantified by cardiac magnetic resonance was reportedly helpful for predicting the risk of ventricular tachyarrhythmias (VTA) in hypertrophic cardiomyopathy (HCM) patients. However, only a few data exist on the clinical implication of semi-quantitative assessment LGE extent in this patient population. The extent of left ventricular (LV) LGE was measured in 310 consecutive HCM patients using semi-quantitative (summing the LV segments with LGE, spatial extent) and quantitative (calculating the LGE volume percentage [vol% of LGE] against the total LV myocardial volume) methods, respectively. LV LGE was detected in 255 (82%) patients, most frequently in the mid-LV septum (n = 160, 52%). During the 49 +/- 45 month follow-up, spontaneous VTA events were observed in 48 patients (16%) including aborted sudden cardiac death (SCD), appropriate defibrillator shock, and non-sustained VTA. The extent of LGE assessed by the two different methods showed a strong positive correlation (Spearman's r = 0.63, P < 0.001). Moreover, there was a graded increase in the rates of VTA with the LGE extent evaluated semi-quantitatively and quantitatively. The extent of LGE was identified as an independent predictor of VTA events and more extensive LGE (positive >/= 4 segments) significantly raised the risk of VTA, irrespective of the presence of conventional risk factors for SCD including family history, unexplained syncope, LV wall thickness >/=30 mm. The extent of LGE, whether assessed by semi-quantitative or quantitative methods, was closely associated with an increased risk of spontaneous VTA events in HCM patients. FAU - Park, Young Jun AU - Park YJ AD - Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. FAU - Park, Seung-Jung AU - Park SJ AD - Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. orthovics@gmail.com. FAU - Kim, Eun-Kyung AU - Kim EK AD - Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. FAU - Park, Kyoung Min AU - Park KM AD - Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. FAU - Lee, Sang-Cheol AU - Lee SC AD - Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. FAU - On, Young Keun AU - On YK AD - Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. FAU - Kim, June Soo AU - Kim JS AD - Department of Medicine, Heart Vascular and Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. LA - eng PT - Comparative Study PT - Journal Article DEP - 20200219 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - AU0V1LM3JT (Gadolinium) SB - IM MH - Aged MH - Cardiomyopathy, Hypertrophic/*complications/diagnostic imaging MH - Electrocardiography MH - Female MH - Gadolinium/*chemistry MH - Heart Ventricles/pathology MH - Humans MH - Male MH - Middle Aged MH - Risk Factors MH - Tachycardia, Ventricular/*complications/*diagnosis/diagnostic imaging PMC - PMC7031259 COIS- The authors declare no competing interests. EDAT- 2020/02/23 06:00 MHDA- 2020/11/13 06:00 PMCR- 2020/02/19 CRDT- 2020/02/21 06:00 PHST- 2019/09/14 00:00 [received] PHST- 2020/01/31 00:00 [accepted] PHST- 2020/02/21 06:00 [entrez] PHST- 2020/02/23 06:00 [pubmed] PHST- 2020/11/13 06:00 [medline] PHST- 2020/02/19 00:00 [pmc-release] AID - 10.1038/s41598-020-59804-8 [pii] AID - 59804 [pii] AID - 10.1038/s41598-020-59804-8 [doi] PST - epublish SO - Sci Rep. 2020 Feb 19;10(1):2920. doi: 10.1038/s41598-020-59804-8.